European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating another…
Tag: Science
Brain implant patient says OpenAI’s tech helps him communicate with family
Mark using Synchron’s BCI Courtesy: Synchron A 64-year-old named Mark has spent the last year learning…
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain…
Musk says next Neuralink brain implant expected soon, despite issues with the first patient
Jonathan Raa | Nurphoto | Getty Images Elon Musk said Wednesday that his brain tech startup…
Investors want proof AI will aid drug discovery. Evidence may come in the second half
As investors peer into the future to envision which industries are ripe to be reshaped and…
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October…
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
A sign with the company logo sits outside of the headquarters campus of Eli Lilly and…
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City…
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the…
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration…
Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage trial
Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more…
FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters The…
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
Moderna and Merck released more positive three-year data Monday on their experimental vaccine, given to patients…